Buyer's guide · Research

Planning Product Studies: When a Supplement or Personal Care Brand Needs In Vitro, Clinical or Dermatological Testing

How brands decide which studies a claim needs (in vitro, human or dermatological), what regulators expect, and how to brief a study.
By Amulya Labs Technical TeamPublished 15 November 20265 min read

Most brands commission a study for one of three reasons: to support a claim, to show a product is safe or well tolerated in use, or to understand how a formulation behaves before scaling it. The study you need depends on which of these you are trying to do, the claim you want to make, and the market you are selling into. Commissioning the wrong study, or the right study with the wrong design, is an expensive way to end up with data you cannot use.

This guide is for brand owners and product teams planning studies on supplements, herbal products or personal care products. It is general guidance, not regulatory advice.

Start from the claim, not the test

Record the exact claim, in the wording intended for the label and for advertising. Then ask what evidence would convince a sceptical regulator that the claim is true for this product.

The standard is broadly similar across major markets:

  • United States, supplements. FDA's guidance on substantiation for dietary supplement claims describes the "competent and reliable scientific evidence" standard for structure/function claims. Structure/function claims must also be notified to FDA and carry the required disclaimer (21 CFR 101.93).
  • United States, advertising. The Federal Trade Commission's Health Products Compliance Guidance explains how it evaluates support for health claims, including that evidence should be relevant to the specific product and claim.
  • European Union, food supplements. Health claims on foods are governed by Regulation (EC) No 1924/2006, which works from a list of authorised claims rather than company-held evidence alone. Check what is permitted before commissioning a study intended to support a new claim.
  • European Union, cosmetics. Claims must meet the common criteria in Regulation (EU) No 655/2013, including evidential support, under the framework of Regulation (EC) No 1223/2009.

A practical consequence: a study on an ingredient is not always evidence for a finished product that contains a different amount, form or combination. Regulators and advertising authorities look at relevance.

The main study types

In vitro studies

Laboratory studies on cells, tissues, enzymes or chemical systems. They are fast, comparatively inexpensive and useful for screening, mechanism work and comparing formulation options.

Good for: early development decisions, supporting a mechanism story, screening ingredients or batches, and some safety endpoints for cosmetics.

Limits: results in a dish do not show that a product works in people at the dose consumed. In vitro data alone is rarely enough to support a consumer-facing efficacy claim for a supplement.

Animal studies

Animal studies can answer some safety and pharmacology questions that cannot yet be addressed otherwise, and some regulators still require them for certain product types.

Watch-outs: for cosmetics, the EU prohibits animal testing of finished cosmetic products and ingredients for cosmetic purposes, and the marketing of cosmetics tested on animals for that purpose (European Commission: ban on animal testing). Several other markets have similar rules. Check the destination market before commissioning any animal work for a cosmetic or personal care product, and consider validated non-animal methods first.

Human studies

Studies in people range from small open-label tolerance studies to randomised, placebo-controlled trials.

Good for: efficacy claims, tolerance, consumer-perceived benefits and, for supplements, the evidence regulators and advertising authorities weigh most heavily.

Design points to decide early:

  • Population (who, how many, inclusion and exclusion criteria)
  • Comparator (placebo, active control, or baseline only), and whether participants and investigators are blinded
  • Primary endpoint, defined before the study starts, and how it is measured
  • Dose, duration and the exact product used, ideally from a documented production batch
  • Ethics committee approval and informed consent. International guidance on good clinical practice is published by ICH (efficacy guidelines, E6), and the ethical principles are set out in the World Medical Association's Declaration of Helsinki. Local regulations on registration and approval also apply.

Dermatological studies

For skin and hair products: patch tests for irritation and sensitisation potential, in-use tolerance studies, and instrumental or expert-graded efficacy studies (for example hydration, sebum or visible signs).

Good for: "dermatologically tested" type claims, tolerance claims and measurable cosmetic benefits. Be precise about what was tested and on whom; the claim on pack should reflect the study, not round it up.

A simple decision guide

Your goal Usually start with Usually needed to support a consumer claim
Choose between formula options In vitro or analytical comparison Not applicable
Support a supplement structure/function claim Review of existing literature on the same ingredient and dose Human data relevant to the product and claim
Show a skin product is well tolerated Patch test In-use tolerance study under dermatological supervision
Make a measurable cosmetic efficacy claim Pilot in-use study Controlled study with instrumental or expert assessment
Explore mechanism In vitro Not usually sufficient alone

How to brief a study

A good brief saves weeks. Include:

  1. The exact claim wording and target markets.
  2. The finished product, its batch, and any comparator or placebo you can supply.
  3. What you already know: literature, previous studies, ingredient supplier data.
  4. Budget and timeline, and whether you need publication-quality reporting.
  5. Who owns the data and the report, and whether the results can be published.

How we approach this at Amulya Labs

Amulya Research Centre, our contract research arm, runs in vitro, animal, human and dermatological studies, with doctors and consultants engaged project by project. Because it sits alongside our manufacturing, a study can use the same documented batches you will sell. Studies are designed around the intended claim and the target market. If a proposed study design is unlikely to substantiate the intended claim, we will advise before work begins.

This guide is general information, not legal or regulatory advice. Claims rules differ by market and product category.

Planning a product?

Send us your brief and we will come back with a formulation approach, documentation list and next steps.